Quantbot Technologies LP Sells 6,986 Shares of Trupanion, Inc. $TRUP

Key Points

• Quantbot Technologies LP has reduced its stake in Trupanion, Inc. by 22.5%, now holding 24,117 shares valued at approximately $899,000.
• Insider sales were notable, with COO John R. Gallagher and CFO Fawwad Qureshi selling 4,000 and 2,534 shares, respectively, leading to significant decreases in their stock ownership.
• Trupanion's latest earnings report revealed a profit of $0.22 per share, exceeding analysts' expectations and showing a 12.3% increase in revenue compared to the prior year.

Quantbot Technologies LP lowered its position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 22.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 24,117 shares of the financial services provider's stock after selling 6,986 shares during the period. Quantbot Technologies LP owned 0.06% of Trupanion worth $899,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in TRUP. Wells Fargo & Company MN boosted its holdings in Trupanion by 44.1% in the fourth quarter. Wells Fargo & Company MN now owns 15,798 shares of the financial services provider's stock worth $761,000 after acquiring an additional 4,836 shares in the last quarter. Raymond James Financial Inc. bought a new position in Trupanion in the fourth quarter worth approximately $593,000. First Trust Advisors LP bought a new position in Trupanion in the fourth quarter worth approximately $7,083,000. Dimensional Fund Advisors LP boosted its holdings in Trupanion by 112.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock worth $13,204,000 after acquiring an additional 144,828 shares in the last quarter. Finally, MetLife Investment Management LLC boosted its holdings in Trupanion by 5.7% in the fourth quarter. MetLife Investment Management LLC now owns 20,132 shares of the financial services provider's stock worth $970,000 after acquiring an additional 1,088 shares in the last quarter.

Trupanion Stock Up 0.3%

Shares of TRUP stock traded up $0.14 during trading hours on Friday, reaching $46.36. The company had a trading volume of 536,451 shares, compared to its average volume of 582,648. Trupanion, Inc. has a 12 month low of $31.00 and a 12 month high of $57.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.69 and a quick ratio of 1.69. The business has a fifty day simple moving average of $50.10 and a 200-day simple moving average of $44.06. The company has a market cap of $1.99 billion, a price-to-earnings ratio of 178.31 and a beta of 1.78.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The financial services provider reported $0.22 EPS for the quarter, beating analysts' consensus estimates of ($0.03) by $0.25. The company had revenue of $353.56 million during the quarter, compared to the consensus estimate of $346.73 million. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.Trupanion's revenue was up 12.3% on a year-over-year basis. During the same period last year, the business posted ($0.14) earnings per share. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, research analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on TRUP shares. Cantor Fitzgerald upgraded Trupanion to a "hold" rating in a report on Wednesday, August 13th. Piper Sandler raised their target price on Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a report on Friday, August 8th. Stifel Nicolaus raised their target price on Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a report on Friday, August 8th. Finally, Lake Street Capital dropped their target price on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a report on Friday, May 2nd. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $54.17.

Insider Buying and Selling

In related news, insider Brenna Mcgibney sold 2,390 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $45.17, for a total transaction of $107,956.30. Following the completion of the sale, the insider directly owned 1,317 shares of the company's stock, valued at approximately $59,488.89. This trade represents a 64.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Fawwad Qureshi sold 2,800 shares of the stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $45.56, for a total value of $127,568.00. Following the sale, the chief financial officer directly owned 6,451 shares of the company's stock, valued at $293,907.56. The trade was a 30.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,390 shares of company stock valued at $245,238 over the last ninety days. 5.42% of the stock is currently owned by company insiders.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.